

Takeda Biopharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 265.01 Cr
- Paid Up Capital ₹ 215.51 Cr
- Company Age 10 Year, 29 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 0.36%
- Profit Growth 39.53%
- Ebitda 68.43%
- Net Worth 5.99%
- Total Assets -12.25%
About Takeda Biopharmaceuticals India
Takeda Biopharmaceuticals India Private Limited (TBIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 15 April 2015 and has a history of Ten years. Its registered office is in Gurugram, Haryana, India.
The Corporate was formerly known as Baxalta Bioscience India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 265.01 Cr and a paid-up capital of Rs 215.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Takeda Biopharmaceuticals India Private Limited India is Gunjan Malhotra as COMPANY SECRETARY. Rahul Kedia, Anjana Narain, Annapurna Das, and One other member serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909HR2015FTC055144
- Company No.
055144
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
15 Apr 2015
- Date of AGM
06 Dec 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Takeda Biopharmaceuticals India?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gunjan Malhotra ![]() | Company Secretary | 05-Jul-2016 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rahul Kedia ![]() | Director | 25-Sep-2024 | Current |
Anjana Narain ![]() | Director | 08-Nov-2024 | Current |
Annapurna Das ![]() | Director | 04-Jun-2024 | Current |
Anoop Kamat ![]() | Director | 23-Apr-2021 | Current |
Financial Performance of Takeda Biopharmaceuticals India.
Takeda Biopharmaceuticals India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.36% increase. The company also saw a substantial improvement in profitability, with a 39.53% increase in profit. The company's net worth moved up by a moderate rise of 5.99%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Takeda Biopharmaceuticals India?
In 2023, Takeda Biopharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Mobisevak Solutions Llp
Anjana Narain is a mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Takeda Biopharmaceuticals India?
Takeda Biopharmaceuticals India has a workforce of 195 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Takeda Biopharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Takeda Biopharmaceuticals India's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Takeda Biopharmaceuticals India
Recent activity within the organization
- Annual General Meeting
Takeda Biopharmaceuticals India Private Limited last Annual general meeting of members was held on 06 Dec 2024 as per latest MCA records.
- Director Appointment
Anjana Narain was appointed as a Director was appointed as a Director on 08 Nov 2024 & has been associated with this company since 6 months 5 days .
- Director Appointment
Rahul Ganesh Kedia was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 7 months 18 days .
- Director Appointment
Annapurna Das was appointed as a Director was appointed as a Director on 04 Jun 2024 & has been associated with this company since 11 months 9 days .
- Balance Sheet
Takeda Biopharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Director Appointment
Anoop Kishore Kamat was appointed as a Director was appointed as a Director on 23 Apr 2021 & has been associated with this company since 4 years 20 days .
Recent News, Updates & Announcement
- Takeda partners with BIRAC.
The local-to-global initiative will support healthcare innovation and technological advancement for comprehensive solutions catering to healthcare needs Takeda signed a three-year MoU with the Biotech.
Frequently asked questions
What is the Incorporation or founding date of Takeda Biopharmaceuticals India Private Limited?
Takeda Biopharmaceuticals India Private Limited was incorporated on 15 Apr 2015.
What is authorized share capital and paid-up capital of Takeda Biopharmaceuticals India Private Limited?
The authorized share capital of Takeda Biopharmaceuticals India Private Limited is ₹ 265.01 Cr and paid-up capital is ₹ 215.51 Cr.
Who are the current board members & directors of Takeda Biopharmaceuticals India Private Limited?
Currently 5 directors are associated with Takeda Biopharmaceuticals India Private Limited.
- Rahul Ganesh Kedia
- Anjana Narain
- Gunjan Malhotra
- Annapurna Das
- Anoop Kishore Kamat
What is the registered address of Takeda Biopharmaceuticals India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Takeda Biopharmaceuticals India Private Limited is 6Th Floor Tower C Building No. 8 Dlf Cyber City, Phase Ii India, Gurgaon, Haryana, 122001.
What is the corporate identification number (CIN) and company number of Takeda Biopharmaceuticals India Private Limited?
The corporate identification number (CIN) of Takeda Biopharmaceuticals India Private Limited is U51909HR2015FTC055144 and the company number is 055144 as per Ministry of Corporate Affairs (MCA).
What is the official website of Takeda Biopharmaceuticals India Private Limited?
The Official website of Takeda Biopharmaceuticals India Private Limited is https://www.takeda.com
What has been the recent revenue trend for Takeda Biopharmaceuticals India Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Takeda Biopharmaceuticals India Private Limited has risen by 0.36%.
How many employees does Takeda Biopharmaceuticals India Private Limited currently have?
As Per 2023 financial reports, 195 employees are currently employed by Takeda Biopharmaceuticals India Private Limited.
What change has been observed in the net worth of Takeda Biopharmaceuticals India Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Takeda Biopharmaceuticals India Private Limited has experienced an upsurge of 5.99%.
When was the last Balance Sheet of Takeda Biopharmaceuticals India Private Limited filed with the ROC?
The most recent Balance Sheet for Takeda Biopharmaceuticals India Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Vishvajeet SinghDirector
- Priyank ParakhDirector
- John YooDirector
- Aparna JetlyDirector
OG
Ongmu GombuDirectorHL
Hyun LeeAdditional DirectorVS
Vineet SinghalDirectorSF
Serina FischerDirector
Similar Companies Based on Pharmaceutical Retailers & Distributors
- Wellness Forever Medicare Limited Mumbai, Maharashtra, India
- Sun Pharma Distributors Limited Mumbai, Maharashtra, India
- Novartis Healthcare Private Limited Mumbai, Maharashtra, India
- Mylan Pharmaceuticals Private Limited Hyderabad, Telangana, India
- Msd Pharmaceuticals Private Limited New Delhi, Delhi, India
- Aster Dm Healthcare Limited Bangaluru, Karnataka, India
- Reckitt Benckiser Healthcare India Private Limited Gurugram, Haryana, India
- Apollo Hospitals Enterprise Limited Chennai, Tamil Nadu, India